Cogent Biosciences Inc (COGT) — Working Capital to Net Assets Ratio
Cogent Biosciences Inc (COGT) has a Working Capital to Net Assets ratio of 133.0% as of December 2025. Working capital of $846.40 Million (current assets of $910.36 Million minus current liabilities of $63.95 Million) is measured against net assets of $636.37 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Cogent Biosciences Inc Working Capital to Net Assets (2015–2025)
This chart shows how Cogent Biosciences Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the ratio stands at 133.0%, reflecting working capital of $846.40 Million against net assets of $636.37 Million USD. Explore investment intensity of Cogent Biosciences Inc to see how much of total assets are deployed in long-term investments.
Annual Working Capital to Net Assets for Cogent Biosciences Inc (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Cogent Biosciences Inc from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Cogent Biosciences Inc assets under control.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 133.0% | $846.40 Million | $636.37 Million | $910.36 Million | $63.95 Million | ▲ +39.1 pp |
| 2024 | 93.9% | $240.76 Million | $256.29 Million | $296.47 Million | $55.71 Million | ▲ +3.7 pp |
| 2023 | 90.2% | $232.60 Million | $257.80 Million | $270.77 Million | $38.17 Million | ▼ -2.9 pp |
| 2022 | 93.1% | $238.12 Million | $255.74 Million | $264.97 Million | $26.85 Million | ▼ -2.9 pp |
| 2021 | 96.0% | $205.56 Million | $214.18 Million | $222.63 Million | $17.08 Million | ▼ -2.8 pp |
| 2020 | 98.8% | $231.82 Million | $234.67 Million | $244.91 Million | $13.09 Million | ▲ +12.7 pp |
| 2019 | 86.1% | $27.34 Million | $31.76 Million | $40.59 Million | $13.25 Million | ▼ -7.0 pp |
| 2018 | 93.1% | $56.06 Million | $60.23 Million | $81.00 Million | $24.95 Million | ▼ -17.1 pp |
| 2017 | 110.2% | $31.19 Million | $28.30 Million | $42.38 Million | $11.19 Million | ▼ -6.2 pp |
| 2016 | 116.4% | $60.99 Million | $52.39 Million | $69.73 Million | $8.74 Million | ▼ -4.1 pp |
| 2015 | 120.6% | $83.81 Million | $69.52 Million | $91.10 Million | $7.29 Million | — |